Evidence map›Paper›PMID 31998561›Full record

ArticlePeerJ2020

Organic acids and 2,4-Di-

Wattana Pelyuntha, Chaiyavat Chaiyasut, Duangporn Kantachote, Sasithorn Sirilun

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Nutrients · 2025
    Review
  7. Article
  8. Efficacy of 2,4-Di-ACS omega · 2024
    Article
  9. Control ofFoods (Basel, Switzerland) · 2023
    Article
  10. Antibiofilm Activity ofLife (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Article
  13. Weissella: An Emerging Bacterium with Promising Health Benefits.Probiotics and antimicrobial proteins · 2021
    Review
  14. Review
  15. Complete Genome Sequence ofFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Wattana PelyunthaInnovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.ORCID 0000-0002-3357-9325
Chaiyavat ChaiyasutInnovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
Duangporn KantachoteDepartment of Microbiology, Faculty of Science, Prince of Songkla University, Hat Yai, Thailand.ORCID 0000-0003-2010-5988
Sasithorn SirilunInnovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.ORCID 0000-0002-1508-2358
Chiang Mai University · THPrince of Songkla University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodIn this study, the cell-free culture supernatant (CFCS) of

resultBased on strong inhibition the growth of

conclusion

Indexed as

2,4 Di-tert-butylphenolAnti-salmonella compoundCell-free culture supernatantLactic acid bacteriaSalmonella TyphiVirulence factorWeissella confusa

Identifiers

PMID31998561
PMCPMC6977521
OpenAlexW3000414096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.